This week's roundup includes tackling greenwashing, advice on setting aside capital to cover costs, and news of more 'carelessness and incompetence' over BSPS advice.
Price fixing
DOJ resolves criminal antitrust charges against big pharma, with a novel twist as businesses agree to divest key product lines.